- Head of Multi-Asset Strategy
United Kingdom, Intermediary
Change
The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.
The market outlook is without question a challenging one, and there is no quick fix and no single “bridge” that will get asset owners where they need to go. But I believe there are effective incremental steps that can be taken to help improve a portfolio’s return potential, including the following ideas.
Add a specific allocation to defensive equities
To demonstrate the potential benefit of defensive investing, Figure 1 illustrates a hypothetical strategy that captures 95% of the return of the S&P 500 in up months but only 85% in down months. Not surprisingly, the strategy adds value when the S&P 500 falls, including during bear markets (shaded areas). But it also holds its own in bull markets, when it might be expected to struggle. After all, even in a bull market there are ups and downs, and a strategy that can limit downside can leverage the power of compounding to improve results over time.
Figure 1
Asset owners with a traditional equity portfolio (growth, value, core) may miss out on factors related to defensiveness, such as price stability (e.g., low volatility) and earnings stability. One idea for filling this gap is “compounders” — equity strategies focused on companies with high and stable free-cash-flow yield and the potential to grow modestly but steadily over time, all in the pursuit of high-single-digit or low-double-digit returns. This category includes portfolio managers we think of as “core compounders,” based on the way they pick companies, as well as listed infrastructure and listed real estate strategies.
High-single-digit or low-double-digit returns could represent significant alpha in the next decade. In addition, valuation could be a tailwind for some defensive approaches, given the category’s weak COVID-era performance. Some of these strategies (e.g., listed infrastructure) may also offer the benefit of inflation hedging, which could add to their appeal in the current environment. Lastly, it is possible that in some scenarios, fixed income will be a less effective hedge against an equity market sell-off than it has been historically, which could make defensive equities all the more attractive.
Take advantage of thematic and opportunistic investments
I define thematic investing as trying to capture structural trends that will change the world over a period of five to 10 years (or more) in ways the market hasn’t fully recognized. Today, fintech, energy infrastructure, and emerging market development are among the themes I’m most excited about.
Opportunistic investing is about taking advantage of market dislocations or negative investor sentiment, which can create massive tailwinds when fundamentals (and sentiment) inflect — a process that often plays out over a shorter cycle (three to five years) than thematic. Opportunistic investors seek to “monetize” a longer time horizon by being a liquidity provider when the market is shying away from a region, asset class, or approach. Given that there is ample liquidity today, I see fewer of these opportunities at the moment, but Japan may fit the bill and China could soon as well.
Both thematic and opportunistic investments can potentially benefit from tailwinds that aren’t reliant on the business cycle or economic growth, which means they are less dependent on the state of the broad capital markets and may add some diversification to a portfolio. Success factors include identifying the right themes or opportunities and then finding the related securities that are most attractive at any given point in the cycle.
More stepping stones
Here’s a complete list of my “stepping stones” investment ideas, including thoughts on equities, fixed income, and private equity.
Expert
Related insights
Showing
of
Insights Posts
URL References
Related Insights
Stay up to date with the latest market insights and our point of view.
Read next
Showing
of
Insights Posts
2024 Insurance Outlook: Position portfolios for the unexpected
Tim Antonelli offers two critical ideas for insurers' 2024 investment planning: doubling down on diversification and rethinking risk, including geopolitical and default risk.
Article
2024-12-31
Trends and transformation: Ideas for 2024
Explore our latest views on risks and opportunities across the global capital markets as we look ahead @to 2024
Article
2024-06-30
Beyond China: what does the rest of the EM equity world have to offer?
For investors contemplating a separate allocation to EM ex-China equities, members of our iStrat Team share their research on the composition of the opportunity set, the growing divergence in the behavior of EM ex-China equities and Chinese equities, and the long-term market outlook.
Article
2025-11-30
Look below the surface: A contrarian view on China equities
Equity expert, Ben Chen, dives into China's murky investment landscape.
2024-05-31
Monthly Market Snapshot – October 2023
A monthly update on equity, fixed income, currency, and commodity markets.
Whitepaper
2024-11-30
Investing at the biopharma frontier
Rebecca Sykes details groundbreaking innovations happening today in the biopharmaceutical industry. She explains key advancements and the investment landscape for therapies targeting diabetes, cancer, and Alzheimer's disease, three of the deadliest and most expensive diseases facing the world today.
Video
2024-11-30
EMEA Investment Forum 2023: highlights
In this short video we share highlights from Wellington's 2023 EMEA Investment Forum, "The only constant is change" and explore associated expert insights.
2024-10-31
Monthly Market Snapshot – September 2023
A monthly update on equity, fixed income, currency, and commodity markets.
Whitepaper
2024-09-30
Novel therapies changing the course of health care
Several new drug classes represent a growing investment opportunity set that could reshape the health care sector.
Article
2024-10-31
Thematic investing focus: a new era for medical innovation
Advances in science, tools and technologies are transforming the face of healthcare, revolutionising the diagnosis and treatment of complex diseases. How can thematic investors identify promising opportunities?
Article
2024-09-30
Financial Market Review: Third quarter 2023
A monthly update on equity, fixed income, currency, and commodity markets.
Whitepaper
2024-10-31
URL References
Related Insights
Look below the surface: A contrarian view on China equities
Continue readingBy
Ben Chen